GLYCOPRESS INDUS  

Indacaterol Maleate Hemihydarate and Glycopyrronium Bromide (Glycopyrrolate IP) Powder for inhalation 110mcg / 50 mcg

GLYCOPRESS INDUS is a prescription medication that combines Indacaterol Maleate Hemihydrate and Glycopyrronium Bromide (Glycopyrrolate IP) for the management of chronic obstructive pulmonary disease (COPD). This combination powder for inhalation provides dual bronchodilation by targeting different receptors in the respiratory tract, making it highly effective in relieving symptoms and improving lung function.

Uses

Together, indacaterol and glycopyrronium help to control COPD by promoting airway relaxation, which opens up the airways and facilitates breathing. The purpose of this drug is:

• Improving Lung Function: The combination of Indacaterol and Glycopyrronium helps improve lung function, allowing for better airflow and reduced shortness of breath.
• Reducing COPD Exacerbations: Regular use of GLYCOPRESS INDUS helps in reducing the frequency and severity of COPD exacerbations.

Dosage

The recommended dosage of GLYCOPRESS INDUS is one inhalation of the 110mcg/50mcg powder once daily. It is crucial to use this medication regularly, at the same time each day, to maintain its effectiveness. Follow these steps for proper inhalation:

1. Prepare the Inhaler: Ensure the inhaler is ready for use.  
2. Inhale the Medication: Breathe out fully, place the mouthpiece in your mouth, and close your lips around it. Breathe in deeply and steadily to ensure the powder reaches deep into your lungs.
3. Hold Your Breath: After inhaling, hold your breath for about 10 seconds to allow the medication to settle in your airways.
4. Repeat if Necessary: If instructed by your healthcare provider, repeat the inhalation process for the recommended number of doses.

Side Effects

Like all medications, GLYCOPRESS INDUS may cause side effects.  Common side effects include:

• Dry Mouth: Glycopyrronium may cause dryness in the mouth. Drinking water and maintaining good oral hygiene can help alleviate this symptom.
• Cough: Some users may experience a mild cough shortly after inhalation.
• Headache: Headaches can occur but are usually mild and temporary.
• Dizziness: A feeling of dizziness or lightheadedness may occur in some individuals.
• Nausea: Mild nausea can be a side effect but typically resolves on its own.

If you experience severe side effects such as difficulty breathing, swelling of the face or throat, or severe rash, seek medical attention immediately.

Price

The cost of GLYCOPRESS INDUS can vary depending on the location and the pharmacy. In India, the price for a month’s supply can range from ₹2000 to ₹2500. It is advisable to check with local pharmacies or online platforms for the most accurate pricing and potential discounts.

Mechanism of Action

GLYCOPRESS INDUS combines two active ingredients with distinct mechanisms:

• Indacaterol: A long-acting beta2-adrenergic agonist (LABA) that relaxes the smooth muscles in the airways, providing bronchodilation and improving airflow.
• Glycopyrronium: A long-acting muscarinic antagonist (LAMA) that blocks the action of acetylcholine on muscarinic receptors, preventing bronchoconstriction and mucus secretion.

Administration

GLYCOPRESS INDUS is administered using a dry powder inhaler device, designed to deliver the medication directly to the lungs. The inhaler device should be used correctly to ensure optimal drug delivery. Patients should receive training on the proper use of the inhaler from their healthcare provider.

Storage

Store GLYCOPRESS INDUS in a cool, dry place away from direct sunlight and moisture. Keep the inhaler device in its original packaging until use to protect it from humidity. Do not store the inhaler in extreme temperatures, such as in a car or freezer.

Precautions

Before using GLYCOPRESS INDUS, inform your healthcare provider if you have any of the following conditions:

• Allergies: Any known allergies to Indacaterol, Glycopyrronium, or any other ingredients in the medication.
• Heart Conditions: History of heart disease, arrhythmias, or high blood pressure.
• Glaucoma: A history of narrow-angle glaucoma.
• Prostate Problems: Difficulty urinating due to an enlarged prostate.

Additionally, inform your healthcare provider of all medications and supplements you are currently taking to avoid potential drug interactions.

Conclusion

GLYCOPRESS INDUS is a potent combination of Indacaterol Maleate Hemihydrate and Glycopyrronium Bromide, offering effective management for COPD. Its dual bronchodilator action helps improve lung function, reduce symptoms, and decrease the frequency of exacerbations. With proper usage and adherence to dosage instructions, GLYCOPRESS INDUS can significantly enhance the quality of life for individuals with COPD. Always consult your healthcare provider for personalized advice and information regarding your treatment plan. Steris Healthcare Pvt Ltd, operating as Sterispharma since its founding by expert professionals in the pharmaceutical industry in February 2018, is based in Navi Mumbai. The company is certified by WHO, GMP, and ISO, emphasizing its commitment to quality and safety. Sterispharma focuses on providing high-quality drugs at affordable prices throughout India, adhering strictly to WHO guidelines. Offering the convenience of an online pharmacy, customers can easily purchase medicines with home delivery options available. Sterispharma's mission is to supply a broad range of healthcare products to meet the diverse needs of the medical community. From advanced treatments and medications for rare conditions to essential health necessities, Sterispharma aims to serve the extensive demands of the healthcare industry. You can order medicines from Sterispharma through their websites, sterisonline and sterispharma. Their extensive product lineup includes treatments for Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology.

For further information 

Email: info@sterispharma.com /  contact@sterispharma.com

Call/WhatsApp:  7877551268, 7849827488 

BUY NOW